Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	925.99	1,010	985.62	688.77	446.2	445.87
Trading Asset Securities	90.14	58	115.17	340.55	581.01	580.43
Cash & Short-Term Investments	1,016	1,068	1,101	1,029	1,027	1,026
Cash Growth	-3.47%	-3.02%	6.94%	0.21%	0.09%	-1.98%
Accounts Receivable	213.84	189.28	161.69	154.55	93.52	135.81
Other Receivables	4.14	4.28	2.44	3.47	3.68	1.65
Receivables	217.98	193.56	164.14	158.02	97.2	137.46
Inventory	144.93	129.35	126.33	135.93	196.96	99.45
Other Current Assets	19.85	16.12	13.78	18.06	17.46	7.11
Total Current Assets	1,399	1,407	1,405	1,341	1,339	1,270
Property, Plant & Equipment	158.22	151.71	157.72	143.24	137.33	94.48
Other Intangible Assets	21.07	21.57	20.43	21.07	22.06	22.54
Long-Term Deferred Tax Assets	9.62	11.18	8.45	9.27	10.21	7.67
Long-Term Deferred Charges	-	-	0.88	0.69	0	0.13
Other Long-Term Assets	4.8	3.84	4.49	6.89	5.5	2.94
Total Assets	1,593	1,595	1,597	1,522	1,514	1,398

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	78.32	75.6	68.32	66.91	92.09	53.89
Accrued Expenses	15.57	31.99	33.12	32.09	36.98	32.75
Current Portion of Leases	2.22	1.28	3.86	4.02	0.31	0.58
Current Income Taxes Payable	11.6	7.69	6.59	3.26	2.15	3.84
Current Unearned Revenue	29.64	31.09	30.7	16	22.99	25.21
Other Current Liabilities	91.76	48.34	24.19	16.11	33.94	23.45
Total Current Liabilities	229.11	195.99	166.79	138.39	188.47	139.73
Long-Term Leases	2.87	1.86	2.67	6.32	5.8	0.79
Long-Term Unearned Revenue	0.47	0.22	0.81	2.3	1.85	3.54
Long-Term Deferred Tax Liabilities	-	-	-	-	0.15	-
Other Long-Term Liabilities	13.44	13.36	6.16	6.41	4.15	8.43
Total Liabilities	245.89	211.43	176.42	153.42	200.42	152.49

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	112.13	112.13	112.12	112.12	112.12	80
Additional Paid-In Capital	901.1	899.04	903.81	905.22	907.56	937.6
Retained Earnings	372.95	384.03	413.05	362.04	294.05	228.2
Treasury Stock	-	-	-10.09	-10.09	-	-
Comprehensive Income & Other	-39.47	-11.71	1.7	-0.22	-0.22	-0.22
Shareholders' Equity	1,347	1,383	1,421	1,369	1,314	1,246
Total Liabilities & Equity	1,593	1,595	1,597	1,522	1,514	1,398

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.08	3.14	6.53	10.34	6.11	1.37
Net Cash (Debt)	1,011	1,064	1,094	1,019	1,021	1,025
Net Cash Growth	-3.51%	-2.72%	7.39%	-0.21%	-0.37%	-2.11%
Net Cash Per Share	9.00	9.50	9.81	9.25	9.07	9.11
Filing Date Shares Outstanding	112.13	112.13	111.87	112.12	112.12	112
Total Common Shares Outstanding	112.13	112.13	111.87	112.12	112.12	112
Working Capital	1,170	1,211	1,238	1,203	1,150	1,131
Book Value Per Share	12.01	12.34	12.70	12.21	11.71	11.12
Tangible Book Value	1,326	1,362	1,400	1,348	1,291	1,223
Tangible Book Value Per Share	11.82	12.15	12.52	12.02	11.52	10.92
Buildings	-	73.26	73.38	73.28	67.53	66.75
Machinery	-	83.13	81.95	75.2	71.87	67.29
Construction In Progress	-	79.79	76.3	55.56	52.33	8.65

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error